Marketable Securities, Current in USD of Nuvation Bio Inc. from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Nuvation Bio Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2020 to Q3 2025.
  • Nuvation Bio Inc. Marketable Securities, Current for the quarter ending September 30, 2025 was $450M, a 13.3% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)

Nuvation Bio Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $450M -$69M -13.3% Sep 30, 2025 10-Q 2025-11-03
Q2 2025 $360M -$183M -33.7% Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $414M -$149M -26.4% Mar 31, 2025 10-Q 2025-05-07
Q4 2024 $467M -$102M -17.9% Dec 31, 2024 10-Q 2025-11-03
Q3 2024 $519M -$75.8M -12.7% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $543M -$38M -6.53% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $562M -$54.1M -8.77% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $569M +$8.65M +1.55% Dec 31, 2023 10-K 2025-03-06
Q3 2023 $595M +$59.7M +11.2% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $581M -$20.6M -3.43% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $617M -$15M -2.37% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $560M -$73.1M -11.5% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $535M +$88.1M +19.7% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $601M +$244M +68.4% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $631M +$446M +240% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $633M +$447M +240% Dec 31, 2021 10-K 2023-03-15
Q3 2021 $447M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $357M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $186M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $186M Dec 31, 2020 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.